Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
This is the 2006 version of HCPCS G9093 - please refer to the 2016 HCPCS code set for the latest version.
Status changed on Sunday, January 01, 2006 to: Add procedure or modifier code
